References
- Waranuch N., Ramachandran C, Weiner N. D. Controlled topical delivery of Cyclosporin-A from nonionic liposomal formulations: Mechanistic aspects. J Lipo Res 1998; 8(2)225–38
- Waranuch N., Ramachandran C, Weiner N. D. Effect of lipid composition on topical delivery of cyclosporin-A from nonionic liposomal formulations: An in vitro study with hairless mouse skin. J Lipos Res 1997; 7(2&3)261–71
- Kao J., Patterson F. K., Hall J. Skin penetration and metabolism of topically applied chemicals in six mammalian species, including man: an in vitro study with benzo[a]pyrene and testosterone. Toxicol Appl Pharmacol 1985; 81(3 Pt 1)502–16
- Ademola J. I., Wester R. C., Maibach H. I. Cutaneous metabolism of theophylline by the human skin. J Invest Dermatol 1992; 98(3)310–4
- Ademola J. I., Chow C. A., Wester R. C., Maibach H. I. Metabolism of propranolol during percutaneous absorption in human skin. J Pharm Sci 1993; 82(8)767–70
- Collier S. W., Storm J. E., Bronaugh R. L. Reduction of azo dyes during in vitro percutaneous absorption. Toxicol Appl Pharmacol 1993; 118(l)73–9
- Storm J. E., Collier S. W., Stewart R. F., Bronaugh R. L. Metabolism of xenobiotics during percutaneous penetration: role of absorption rate and cutaneous enzyme activity. Fundam Appl Toxicol 1990; 15(1)132–41
- Bickers D. R., Dutta-Choudhury T., Mukhtar H. Epidermis: A site of drug metabolism in neonatal rat skin. Studies on cytochrome P-450 content and mixed-function oxidase and epoxide hydrolase activity. Mol Pharmacol 1981; 21: 239–47
- Coomes M. W., Norling A. H., Pohl R. J., Muller D., Fouts J. R. Foreign compound metabolism by isolated skin cells from the hairless mouse. J Pharmacol Exp Ther 1983; 225(3)770–7
- Pohl R. J., Fouts J. R. Cytochrome P-450-dependent xenobiotic metabolizing activity in Zymbal's gland, a specialized sebaceous gland of rodents. Cancer Res 1983; 43(8)3660–2
- Kao J., Hall J., Helman G. In vitro percutaneous absorption in mouse skin: influence of skin appendages. Toxicol Appl Pharmacol 1988; 94(1)93–103
- Maurer G., Loosli H. R., Schreier E., Keller B. Disposition of cyclosporine in several animal species and man. I. Structural elucidation of its metabolites. Drug Metab Dispos 1984; 12(1)120–6
- Kronbach T., Fischer V., Meyer U. A. Cyclosporine metabolism in human liver: identification of a cytochrome P-450III gene family as the major cyclosporine metabolizing enzyme explains interactions of cyclosporine with other drugs. Clin Pharmacol Ther 1988; 43(6)630–5
- Duell E., Fischer V., Fisher G., Astrom A., Voorhees J. Cyclosporine A metabolism by cytochrome P-450III occurs in microsomes from rat liver but not from normal epidermis or psoriatic lesions. J Invest Dermatol 1991; 96(6)827–31
- Vickers A. E., Biggi W. A., Dannecker R., Fischer V. Uptake and metabolism of cyclosporin A and SDZ IMM 125 in the human in vitro skin2 dermal and barrier function models. Life Sci 1995; 57(3)215–24
- Hasumi H., Nishikawa T., Ohtani H. Effect of temperature on molecular structure of cyclosporin A. Biochem Mol Biol Int 1994; 34(3)505–11
- Collier S. W., Bronaugh R. L. Cutaneous metabolism during percutaneous absorption. Pharmacology of the skin, H Mukhtar. CRC Press, Boca Raton, FL. 1992; 111–129